Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chemosensor Detects Cancer Biomarker Neopterin

By LabMedica International staff writers
Posted on 02 Jun 2016
A procedure has been established of molecular imprinting; a synthetic polymer receptor for the neopterin cancer biomarker was devised and used as a recognition unit of a potentiometric chemosensor.

Cancer is no longer a death sentence for the patient, but the best chances of recovery are when the correct treatment is undertaken at an early stage of the disease. More...
This is where the trouble starts, because many tumors develop over a long period without any symptoms.

Scientists at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) devised and fabricated a chemosensor system that will bring us a step closer to the sort of personalized medical diagnosis and cancer prophylaxis in the near future. The most important element of the devised chemosensor is a thin film of the polymer that detects molecules of neopterin. Neopterin, in chemical terminology known as 2-amino-6-(1,2,3-trihydroxypropyl)-1H-pteridin-4-one), is an aromatic compound present in human body fluids, such as serum, urine, and cerebrospinal fluid.

The concentration of this neopterin biomarker rises significantly particularly in the case of certain neoplastic diseases, e.g., malignant lymphoma, although elevated levels of neopterin are also seen in some viral and bacterial infections, as well as in diseases of parasitic etiology. In turn, in transplant patients, increased levels of neopterin signal probable rejection. The device has a recognizing polymer film with molecular cavities from neopterin has been produced on the surface of an electrode. Electrochemical experiments involving the potentiodynamic, cyclic voltammetry(CV), and open circuit potential (OCP) measurements were performed with an SP300 electrochemistry system (BioLogic Science Instruments, Claix, France).

After immersion in artificial blood serum spiked with neopterin, the film on the electrode captured molecules of the latter, thus leading to a decrease in electrical potential in the connected measuring system. The tests showed that the molecular cavities of the polymer were almost entirely filled with molecules of neopterin despite the presence of molecules of similar structure and properties. This result means that the probability of false positive detection (detecting the presence of neopterin in body fluids not containing it) is negligibly small. The new chemical sensor therefore mainly reacts to what it should react to - and nothing else.

Wlodzimierz Kutner, PhD, DSc, a professor of Chemistry and lead author of the study said. “At present, our chemosensor is a piece of laboratory equipment. However, the production of its key element, that is, the recognizing polymer film, does not pose major problems, and the electronics responsible for electrical measurements can easily be miniaturized. There is nothing standing in the way of building simple and reliable diagnostic equipment, based on our development, in just a few years' time, which would be affordable for medical institutions and doctors' surgeries.” The study was published on March 15, 2016, in the journal Biosensors and Bioelectronics.

Related Links:
Institute of Physical Chemistry of the Polish Academy of Sciences
BioLogic Science Instruments

New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Rapid Molecular Testing Device
FlashDetect Flash10
New
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Pathology

view channel
image: Researchers Marco Gustav (right) and MD Nic G. Reitsam (left) discuss the study data (Photo courtesy of Anja Stübner/EKFZ)

AI Model Simultaneously Detects Multiple Genetic Colorectal Cancer Markers in Tissue Samples

Colorectal cancer is a complex disease influenced by multiple genetic alterations. Traditionally, studies and diagnostic tools have focused on predicting only one mutation at a time, overlooking the interplay... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.